NikoleV Posted April 6, 2022 Share Posted April 6, 2022 Advocacy Opportunity, contact information below: "IQVIATM (www.iqvia.com), in partnership with GlaxoSmithKline (GSK), a pharmaceutical company, is currently conducting a research study with patients who have been diagnosed with advanced (stage IIIb, IIIc, or IV) non-small cell lung cancer (NSCLC) by their physician. The study will involve participating in a telephone interview lasting 45-60 minutes. In appreciation of your time, we are offering an honorarium. The research will focus on understanding the NSCLC patient experience. This research may help improve how the patient experience is accounted for in clinical trials for new treatments of NSCLC. The interviews can be scheduled during a time that is convenient for you as we have a range of different time slots. The study is strictly for research purposes; there will be absolutely no sales or promotional activities. The aim of this research is to gain your views and is not in any way promotional. If you are interested, or have any questions, please contact at veronica@global-patients.com" Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.